Lilly(LLY) - 2022 Q3 - Earnings Call Transcript

Eli Lilly and Co (NYSE:LLY) Q3 2022 Earnings Conference Call November 1, 2022 9:00 AM ET Company Participants Joe Fletcher - SVP, IR David Ricks - Chairman, CEO & President Anat Ashkenazi - SVP & CFO Daniel Skovronsky - Chief Scientific and Medical Officer Anne White - SVP & President, Lilly Neuroscience Ilya Yuffa - SVP & President, Lilly International Lilly Research Labs Jake Van Naarden - SVP, CEO, Loxo Oncology & President, Lilly Oncology Michael Mason - SVP & President, Lilly Diabetes Conference Call P ...